Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05266716 · ClinicalTrials.gov registry record · NA
Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
A NA study of Methamphetamine Abuse, sponsored by Affect Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
- 1
- Study location
NCT05266716 is a NA study of Methamphetamine Abuse that has completed, run by Affect Therapeutics. The registered enrollment target is 79 participants, below the 204-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05266716, a NA study of Methamphetamine Abuse, has completed, sponsored by Affect Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of the observational, investigational pilot study is to assess the clinical utility of the Affect digital health platform (the Affect® "app") as part of the Affect program of treatment for methamphetamine-primary stimulant use disorder. The study also will identify elements of the Affect app that enhance engagement of participants in the study toward the goal of improving patient outcomes, including reduction/cessation of stimulant use.
Conditions Studied
Interventions
- BEHAVIORAL Affect Methamphetamine Treatment Program
Study Locations (1)
New York
- Affect Therapeutics - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2021-02-18 |
| Est. Completion | 2022-01-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05266716
The ClinicalTrials.gov registry entry for NCT05266716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (61% lower). The listed sponsor is Affect Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methamphetamine Abuse appearing as the primary indexed condition, and to 1 intervention - of which Affect Methamphetamine Treatment Program is the first listed.
NCT05266716 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05266716 about?
NCT05266716 is a clinical study titled "Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder". The overall purpose of the observational, investigational pilot study is to assess the clinical utility of the Affect digital health platform (the Affect® "app") as part of the Affect program of treatment for methamphetamine-primary stimulant use disorder. The study also will identify elements of th...
What is the current status of trial NCT05266716?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2021-02-18. Estimated completion is 2022-01-07.
What conditions does trial NCT05266716 study?
This clinical trial studies the following conditions: Methamphetamine Abuse.
What interventions are being tested in trial NCT05266716?
The interventions under investigation include: Affect Methamphetamine Treatment Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05266716?
This trial is sponsored by Affect Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05266716 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Theta Burst TMS for Treatment of Methamphetamine Use Disorder
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
-
Mood and Decision-making in Methamphetamine Use Disorder
RECRUITING · NA
-
Contingency Management for Drug Use: Does Age Matter?
ACTIVE NOT RECRUITING · NA
-
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.